The Self-Assembled Nanoparticle-Based Trimeric RBD mRNA Vaccine Elicits Robust and Durable Protective Immunity Against SARS-CoV-2 in Mice

Authors: W. Sun, L. He, H. Zhang, X. Tian, Z. Bai, L. Sun, L. Yang, X. Jia, Y. Bi, T. Luo, G. Cheng, W. Fan, W. Liu & J. Li

Journal: Signal Transduction and Targeted Therapy


Publication - Abstract

September 09, 2021

In a publication written by scientists, Sun et al. 2021, from the CAS Key Laboratory of Pathogenic Microbiology and Immunology at the Chinese Academy of Sciences, endeavored to develop a broad-spectrum multivalent vaccine to combat rapidly emerging variants of SARS-CoV-2. Their approach involved the production of lipid nanoparticle-based trimeric receptor binding domain (RBD) mRNA vaccines using the NanoAssemblr ® microfluidic mixing platform. The formulation showcased strong immune responses in HACE2-transduced mice that were challenged with SARS-Cov-2. The mRNA payload encoded for the trimeric RBD of the SARS-CoV-2 spike (S) protein and the protein ferritin (TF-RBD) which was then encapsulated by lipid nanoparticle formulations. Aside from the TF-RBD vaccine’s ability to induce robust and durable humoral immunity, several pseudoviral assays applied to immunized mice reveal broad spectrum immunity through higher levels of cross-neutralizing antibody responses against the Alpha, as well as Beta variants of SARS-CoV-2. The versatility and fast engineering approach in developing mRNA payloads to incorporate vaccine adjuvants like ferritin as exemplified in this paper can pave the way for further advancements in nanoparticle subunit vaccines that may play a key role in addressing new viral variants of arising infectious diseases.

Advanced Search

  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Articles

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
    • Cell therapy
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads

related content

Publication - Abstract

Lipid nanoparticle (LNP) formulations facilitate tumor uptake and intracellular processing through an enhanced permeation and retention effect (EPR), and currently multiple products are undergoing clinical evaluation.

Read More

Publication - Abstract

Recently, mRNA-based therapeutics have been greatly boosted since the development of novel technologies of both mRNA synthesis and delivery system. Promising results were showed in both preclinical and clinical studies in the field of cancer vaccine, tumor immunotherapy, infectio...
Read More

Sign Up and Stay Informed
Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.